Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extensive clinical experience: nonclassical 21-hydroxylase deficiency.

Maria I New1

  • 1Adrenal Steroid Disorders Program, Department of Pediatrics, Mount Sinai School of Medicine, New York, New York 10029, USA. maria.new@mssm.edu

The Journal of Clinical Endocrinology and Metabolism
|August 17, 2006
PubMed
Summary

Nonclassical congenital adrenal hyperplasia (NC21OHD) is a common genetic disorder causing mild hyperandrogenism. Dexamethasone treatment effectively reverses these symptoms in affected individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FSH-blocking therapeutic for osteoporosis.

eLife·2022
Same author

Brain atlas for glycoprotein hormone receptors at single-transcript level.

eLife·2022
Same author

First-in-class humanized FSH blocking antibody targets bone and fat.

Proceedings of the National Academy of Sciences of the United States of America·2020
Same author

Beyond bone biology: Lessons from team science.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·2020
Same author

Repurposing erectile dysfunction drugs tadalafil and vardenafil to increase bone mass.

Proceedings of the National Academy of Sciences of the United States of America·2020
Same author

Oxytocin regulates body composition.

Proceedings of the National Academy of Sciences of the United States of America·2019

Area of Science:

  • Endocrinology
  • Genetics
  • Pediatrics

Background:

  • Nonclassical congenital adrenal hyperplasia (NC21OHD) due to steroid 21-hydroxylase deficiency is a prevalent autosomal recessive genetic disorder.
  • It affects approximately 1 in 100 individuals in diverse populations and is more common in specific ethnic groups like Ashkenazi Jews.
  • NC21OHD is often underdiagnosed due to mild to moderate hormonal abnormalities, distinguishing it from classical CAH.

Purpose of the Study:

  • To investigate the clinical manifestations and treatment outcomes of nonclassical congenital adrenal hyperplasia (NC21OHD).
  • To highlight the diagnostic challenges and therapeutic strategies for hyperandrogenic symptoms associated with NC21OHD.

Main Methods:

  • Review of clinical symptoms associated with hyperandrogenism in NC21OHD.

Related Experiment Videos

  • Evaluation of the effects of dexamethasone treatment on reversing hyperandrogenic signs and symptoms.

    • Main Results:

    • Hyperandrogenic symptoms in children include advanced bone age, early puberty, and growth disturbances.
    • Adult manifestations range from infertility and acne to hirsutism and polycystic ovaries in females, and testicular adrenal rest tissue in males.
    • Dexamethasone treatment successfully reverses the signs and symptoms of hyperandrogenism.

    Conclusions:

    • Nonclassical congenital adrenal hyperplasia presents with a spectrum of hyperandrogenic symptoms.
    • Dexamethasone is an effective treatment for reversing these symptoms, improving patient outcomes.